Group 1 - Zhejiang Haisheng Medical Equipment Co., Ltd. (Haisheng Medical) has received approval for its IPO application, with CITIC Securities as the sponsor and Tianjian as the accounting firm [1] - Haisheng Medical specializes in the research, production, and sales of anesthesia and monitoring medical devices, serving clinical needs in various departments such as anesthesia, ICU, and emergency [1] - The company has established a sales network covering most provinces in China, with its products used in over 1,000 tertiary hospitals and thousands of medical institutions, including more than 600 top-tier hospitals [1] Group 2 - For the fiscal years 2022 to 2024, Haisheng Medical reported revenues of 267.72 million yuan, 305.88 million yuan, and 303.73 million yuan, respectively, with a net profit of 70.11 million yuan, 78.04 million yuan, and 70.92 million yuan [2] - In 2024, the company experienced a decline in both revenue and net profit, with revenue decreasing by 0.65% and net profit decreasing by 9.12% year-on-year [3] - As of March 2025, the company's total assets were 492 million yuan, a decrease of 0.82% from the previous year, while equity attributable to shareholders increased by 2.93% to 423 million yuan [3]
海圣医疗北交所IPO：一季度营收净利双增，仍有3个履约保函正在履行中
Sou Hu Cai Jing·2025-05-31 01:58